Banguis, Maria Lourdes .
HRN: 26-08-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
CO-AMOXICLAV 625MG (TAB)
01/04/2025
01/11/2025
PO
625mg
Q8
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes